4.6 Letter

High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation

Journal

BRITISH JOURNAL OF HAEMATOLOGY
Volume 162, Issue 2, Pages 282-285

Publisher

WILEY-BLACKWELL
DOI: 10.1111/bjh.12352

Keywords

myelodysplastic syndrome; tumour antigens; PReferentially expressed Antigen of the Melanoma Gene; leukaemia antigens; survival

Categories

Funding

  1. Leukaemia & Lymphoma NI [R2536CNR] Funding Source: researchfish

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available